Beacon Pharma

Representational image. Photo: Collected

Beacon Pharma's profit up on higher earnings

The pharmaceutical manufacturer witnessed over a 335% year-on-year increase in the net profit for the January-March quarter of FY2025-26 compared to the same period of the previous fiscal year.

Beacon Pharmaceuticals Managing Director Ebadul Karim passes away

Beacon Pharma, Eastern Bank, Orion Infusion lift DSEX despite most stocks falling

How pharmas performed against high headwinds

Beacon Pharma: Price Sensitive Information

Beacon Pharma’s profit up on sales growth

Beacon Pharma may export drugs to Syria

Remdesivir pushes up Beacon Pharma’s profit

96% of Covid-19 patients recover in Beacon pharma’s Favipira trial

Beacon Pharma MD tests Covid-19 positive